Junko Ishizaki
- Oncology top 10%
- Molecular Biology
- Pharmacology top 5%
- Pediatrics, Perinatology and Child Health top 10%
- Pharmacology top 10%
- Co-authors
- Koiçhi YokogawaFujio IchimuraKen‐ichi MiyamotoMasaru MimuraEmi NakashimaShoji OhkumaTsutomu ShimadaYoshimichi Sai
- Topics
- Drug Transport and Resistance Mechanisms (18 papers)Pharmacy and Medical Practices (6 papers)Pharmacological Effects and Toxicity Studies (6 papers)
- Cited by
- PharmacologyOncologyTransplantation
- Journals
- SHILAP Revista de lepidopterologíaJournal of Pharmacology and Experimental TherapeuticsInternational Journal of Pharmaceutics
- Partner nations
- JapanUnited StatesCzechia
In The Last Decade
Junko Ishizaki
55 papers receiving 901 citations
Peers
Comparison fields: 5 of 120
- Oncology 278
- Molecular Biology 213
- Pharmacology 154
- Pediatrics, Perinatology and Child Health 132
- Pharmacology 110
Countries citing papers authored by Junko Ishizaki
This map shows the geographic impact of Junko Ishizaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Ishizaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Ishizaki more than expected).
Fields of papers citing papers by Junko Ishizaki
This network shows the impact of papers produced by Junko Ishizaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Ishizaki. The network helps show where Junko Ishizaki may publish in the future.
Co-authorship network of co-authors of Junko Ishizaki
This figure shows the co-authorship network connecting the top 25 collaborators of Junko Ishizaki. A scholar is included among the top collaborators of Junko Ishizaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junko Ishizaki. Junko Ishizaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 51 | |
| 5 | 47 | |
| 6 | 20 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 1 | |
| 10 | 39 | |
| 11 | 4 | |
| 12 | 1 | |
| 13 | 0 | |
| 14 | 3 | |
| 15 | 7 | |
| 16 | 39 | |
| 17 | 17 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 51 |
About Junko Ishizaki
Junko Ishizaki is a scholar working on Pharmacology, Transplantation and Oncology, having authored 61 papers that have together received 931 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (18 papers), Pharmacy and Medical Practices (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). The work is most often cited by research in Pharmacology (154 citations), Oncology (278 citations) and Transplantation (25 citations). Junko Ishizaki has collaborated with scholars based in Japan, United States and Czechia. Frequent co-authors include Koiçhi Yokogawa, Fujio Ichimura, Ken‐ichi Miyamoto, Masaru Mimura, Ken‐ichi Miyamoto, Emi Nakashima, Shoji Ohkuma, Tsutomu Shimada, Yoshimichi Sai and Masaki Aburada. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.